在日本批准药物的监管提交中,应用基于模型的药物开发 (MIDD) 来进行剂量选择
, Tomohiro Sasaki1, Takayuki Katsube2
1Clinical Pharmacology, Otsuka Pharmaceutical Co., Ltd., Osaka, Japan. Sasaki.Tomohiro@otsuka.jp.
Journal of pharmacokinetics and pharmacodynamics
|January 6, 2025
概括
基于模型的药物开发 (MIDD) 在日本越来越多地使用,模型分析支持许多已批准的医疗产品的剂量决定. 这项调查突出了MIDD.
科学领域:
- 药理计量和药物开发研究
- 监管科学 监管科学
- 数据科学在制药领域
背景情况:
- 基于模型的药物开发 (MIDD) 提高了药物开发效率.
- 日本制药制造商协会的一个工作组调查了日本的MIDD应用.
- 了解MIDD的趋势和挑战对于其更广泛的采用至关重要.
研究的目的:
- 分析日本批准产品的MIDD申请调查结果.
- 揭示当前使用MIDD的趋势和挑战.
- 在日本促进MIDD的认识和应用.
主要方法:
- 在2020年1月至2022年3月期间,对日本批准的322种医疗产品进行了调查.
- 建模分析的分析分析在剂量和管理选择中的使用.
- 检查影响建模分析应用的因素.
主要成果:
- 在47.8%的病例中进行了建模分析,在24.2%的病例中进行了明智的剂量选择.
- MIDD经常应用于单克隆抗体,首次指示,孤儿药物和多区域试验.
- 建模分析支持在整个开发阶段和特殊人群中优化剂量,并结合了日本数据.
结论:
- 该调查提供了对日本MIDD当前状况的见解.
- MIDD,特别是建模分析,在优化剂量和管理方面发挥着重要作用.
- 包括解决种族因素在内的MIDD应用对于日本未来的药物开发至关重要.
相关概念视频
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Pharmacokinetic Models: Comparison and Selection Criterion
38
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
38
Drug Discovery: Overview
7.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.4K
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
87
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
87
Drug Dosage Regimen: Overview
3.4K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.4K
Analysis of Population Pharmacokinetic Data
222
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
222


